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Abstract
Coronary arterial disease is the leading cause of death and morbidity in
developing countries. Acute myocardial infarction (A,MI) has traditionally been
considered a disease affecting mostly men, yet women are increasingly at risk due to
obesity and diabetes. However, current trends in the AMI risk for women are not well
understood. This study used archival data on hospital discharges from three states within
the USA to examine the 1O-year trend in presentations of patients to emergency rooms
(ER) with a presenting diagnosis of chest pain and AMI, to document rate changes by

gender over time. We observed a decreasing number of AMIs over

time~

but an

increasing proportion of MI admissions being female, and an especially high rate
observed for minority women. Women with an AMI also have a higher rate of comorbid
obesity and/or diabetes than observed in men. In

addition~

women are more likely to have

comorbid signs or diagnoses with symptoms that could mimic AMI symptoms, and thus

confuse the rapid diagnosis of an AM I. National guidelines stress the importance of a
timely diagnosis of patients presenting with an AM l. To assure equity in access to quality
care for AMI

patients~

both medical professionals and the public may need education

focused on the increasing rate of AM I within the female population.
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ABSTRACT

Coronary arterial disease is the leading cause of death and morbidity in
developing countries. Acute myocardial infarction (AM I) has traditionally been
considered a disease affecting mostly men, yet women are increasingly at risk due to
obesity and diabetes.

However~

current trends in the AMI risk for women are not well

understood. This study used archival data on hospital discharges from three states within
the USA to examine the 1O-year trend in presentations of patients to emergency rooms

(ER) with a presenting diagnosis of chest pain and AMI, to document rate changes by
gender over time. We observed a decreasing number of AM Is over time; but an
increasing proportion of MI admissions being female, and an especially high rate
observed for minority women. Women with an AMI also have a higher rate of comorbid
obesity and/or diabetes than observed in men. In

addition~

women are more likely to have

comorbid signs or diagnoses with symptoms that could mimic AMI

symptoms~

and thus

confuse the rapid diagnosis of an AM I. National guidelines stress the importance of a
tilnely diagnosis of patients presenting with an AMI. To assure equity in access to quality
care for AM I patients, both medical professionals and the public may need education
focused on the increasing rate of AM I within the female population.
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Problem Statement
In order to reduce the mortality and morbidity rate associated coronary artery
disease within the population and predominantly for females the focal point should
converge on how to improve the knowledge and interpretation of the signs and
symptoms of females' presenting with a myocardial infarction, as well as those with
increase risk factors of AMI. There are increase disparities among females at risk for
AMI due to comorbidities and secondary risk factors which proceed to be undjagnosed
and treated based on the obscure cardiac signs and symptoms of females. The AMI
incident rate of females, and more so in minority females, will continue to escalate and
outcomes worsen due to the unsuccessful public health awareness available representing
the female high risk population.
Currently~

the incidents of secondary risk factors associated with AMI are more

prevalent in females than males.

Females at a higher MI risk often have one or more

comorbidities, such as diabetes or obesity., which will likely increase their morbidity and
mortality. Physicians often incorrectly diagnose females presenting to the ER with an
AMI due to the obscure signs and symptoms mimicking other diseases or conditions.
Females improperly diagnosed will lack necessary treatment and lifesaving intervention
merely to exacerbate the existing condition along with the possibility death. Technology
and treatment are readily avai lable to diagnose and aid the M I patients~ however due to
health disparities among females they are less likely to be diagnosed and treated as males
with AMI.

Without an effective education program for health professionals and an
improvement in public health

awareness~

heart disease will continue to be the leading
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cause of death~ particularly for females. Subsequently, if females do not recognize their
personal signs and symptoms of an AMI they will not likely seek appropriate treatment as
well as presence to the ER seeking treatment. The extent of time from the onset of the
symptoms to the time of treatment is critical for enhanced positive outcomes. The
awareness needs to be directed towards elil11inating the disparities within the female
population and heart disease. In acknowledging and recognizing the differences of AMI
between the genders the heaIthcare professionals will be further competent towards
accurately diagnosing and treating males and females in a consistent approach as a result
of correctly diagnosing and providing timely intervention.
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Glossary of Terms
Acute Myocardial infarction (AMI) - Often called heart attack when the blood flow
supply to part of the heart muscle is reduced or stopped.

Acute Coronary Syndrome (ACS) - refers to any group of symptoms attributed to
obstruction of the coronary arteries.
Angiogram-is a test utilizing special dye and camera to take pictures of blood flow in an
artery. It can also be used as an intervention to open blocked blood vessels.
Angioplasty-procedure used to treat patients with a partial or completely occluded artery
using a balloon-tip catheter which is inflated to compress the blockage and widens the

artery for increase blood flow to the heart muscle.
Body Mass Index-body mass index

(BMI)~

which is a person's weight (in kilograms)

divided by the square of his or her height (in meters). A person with a 8MI of 30 or more
is generally considered obese. A person with a BMI equal to or more than 25 is
considered overweight.
Electrocardiogram (ECG/EKG)-A recorded tracing of the electrical activity of the heart.
Catheterization Lab-A department in a medical facility that specializes in cardiac
Catheterization.
C,omorbid - presence of one or more diseases in addition to a primary disease that
Exist
Door-to- Balloon Time-the amount of time the patient presents to the hospital to the time
the patient receives an angioplasty or PC I.
Door-to-Needle Time-amount of time between the patienfs arrivals to the hospital to the
time the patient receives thrombolytic.
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Emergency Medical Service CEMS)-A system of health care professionals providing
services to persons in need of emergency care before arrival to hospital.
Fibrinolytic Therapy-use of phannaceuticals to break up blood clots inside an artery or
cavity of the heart to restore blood flow.
Gastroesophageal Reflux Disease GERD- and is also called Acid Reflux or Heartburn. It
occurs when gastric acids in the stomach go up into the esophagus.
Micro vascular Angina-pain or discomfort in the chest due to inadequate blood flow in
the very small cardiac blood vessels.

Monounsaturated fats-a type of fat found in mostly

canola~

olive, peanut, and other nut

oils.
Mortality-total number of deaths from a given disease in a population during a given
time.
Myocardial Infarction-damage or death of an area of the heart muscle due to an occluded
vessel.
Myocarditis-inflammation of the heart lTIuscle.
Myocardium-the muscular wall of the heart.
Non-ST Elevation Myocardial Infarction (NSTEMI)-A type of heart attack caused by a
partially occluded blood supply to a portion of the heart.
Percutaneous Coronary Intervention (PCI)-medical procedures which mechanically treats
patients with partial or completely occluded vessels.
Presenting Diagnosis-Subjective assessment of chief problem upon admission.
Primary Diagnosis-The condition requiring the most resources for treatment.
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Principal Diagnosis- condition established after medical findings responsible for the
patient admission to the hospital for care.
Reperfusion Therapy-One or more techniques used to restore blood to the heart.
Revascularization-procedure used to relieve severe chest pain in patients unable to
undergo bypass surgery or angioplasty.
Secondary Prevention- a means to treat patients at a high risk for cardiovascular disease
to assist in preventing or rehabilitating potential cardiac patients.

ST -Elevation Myocardial Infarction (STEMI)-a severe heart attack caused by a prolong
decrease of blood flow to the heart muscle and may cause death or disability.
Stent-a wire mesh tube that is inserted into an artery to open or unblock in order for blood
supply to increase to the heart muscle.
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INTRODUCTION

Coronary arterial disease is the leading cause of death and morbidity in developing
countries. Over 17 milhon people died from heart disease globally in 2008, and many of
the cardiac victims who survive have pennanent disabihties, and their quality of life is
often greatly diminished. Heart disease (HD) is expected to remain the number one killer
in the United States over the next decade, and the rate may increase because many
associated risk factors for HD are becoming more common, and many more individuals
are surviving to old age.
It has been the case for many years that heart disease affli9ts predominantly males.
Men and women presenting to the ED with symptoms suggestive of acute cardiac

ischemia, the prevalence of AMI is approximately twofold higher in men than in women
after controlling for presenting characteristics. However, the risk for women has been
changing over the last decade due to the aging population as well as the growing
percentage among women with acute myocardial infarction (AMI) associated risk

factors~

such as diabetes and obesity. However, the increasing trends in the AMI for women are
not well understood in the general

population~

nor are they commonly recognized by

emergency room clinicians who are the first contacts for women with AMI symptoms.
The quality of care problems related to 1ack of recognition of the increasing AMI risk for
women may be exacerbated by the fact that AMI may show substantially different
symptoms in women that those which are commonly accepted for men. Thus it is
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important to understand and document any increasing AMI risk for women who present to
emergency rooms. A delay in a diagnosis of AMI increases a woman's risk of death, as
well as the potential for her having substantial sequellae from the AMI.
This study used archival data on hospital discharges from three states to examine
the 1O-year trend in presentations of patients to emergency rooms (ER) with a presenting
diagnosis of chest pain and MI, to document rate changes by gender over time. The
research questions examined here are:
1) Have hospital admissions for MI in women increased over the last ten years,

compared to the number of admissions for men?
Hypothesis: Women constitute an increasing proportion of AMI admissions
over time, controlling for age and racial risk factors. Women constitute an
increasing proportion of AMI admissions over time, controlling for age and
racial risk factors.
2) Are women more likely than men to have comorbid conditions of diabetes and

obesity?
Hypothesis: Women with an AM I have a greater prevalence of risk

factors~

such as obesity and diabetes than the rate observed for men.
3) Are women admitted to a hospital with an AM I in 2010 more likely than men
to have a comorbid diagnosis of chest pain; muscle

strain~

heart

bum~

gastric

reflux disease or vague complaints that could obscure a diagnosis of AMI than
men?
Hypothesis: A higher proportion of women than men with an AMI have a
cornorbid diagnosis or a complaint that could obscure AM I signs and
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symptoms.

This study improves our understanding of the magnitude of the potential problem
in timely diagnosis of AMI for women. While epidemiological reports on rates of AMls
for men and women are routinely published by the Centers for Disease Control

(CDC)~

these do not examine the magnitude of the problem of delay in AMI diagnosis that
females may face. A better understanding of this phenomenon is needed before
guidelines can be developed on the use of recent laboratory tests routinely for women
who present to the ER with symptoms related to an AMI which do not correspond to
nonnal patterns observed in the male population.
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BACKGROUND

Expectations for Heart Disease in Future Years
The rate of heart disease incidents is not expected to diminish in the near future. It
is estimated that by 2030 the population of those 65 and older will triple compared to
1980. The increase in the aging population is a result of the "baby boomer" generation.
These are people who were born between 1946 and 1964 (Nawrot, Perez, Kunzli,
Munters, & Nemery, 2011; Roger, 2010).
Not only will the number of baby boomers triple in the next few

decades~

but six

out of 10 will have two or more chronic illnesses. The American Heart Association
indicates that over 65 percent wi]] have a body mass index greater than 25 and over 30
percent will have a body mass index of more than 30, which is classified as obese.
Both men and women in the baby boomer generation face an increased risk of
having a heart attack because of declining health. And due to ongoing research and
development, as well as sophisticated medical technology and the growing number of
health-care

communities~

the population's overall life expectancy has increased. This win

result in more patients with multiple risk factors.

Baby boomers differ from previous generations in the number of females who
have entered the work force. The lifestyles of women today are much different compared
to previous

generations~

as more pursue careers in an effort to maintain a certain lifestyle

and help support their family. There is evidence that suggests that an increase in work-
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related stress among women may be a factor in the increased percentage of females
having AMIs (Amsterdam & Robinson,

2008~

Barchielli et a1.; 2010; Bhakta, Mookadam,

& Wilansky, 20 II).

Addressing outdated perceptions
Despite this trend, there is still the perception that heart disease does not affect
women. Many women and health care professionals do not identify heart disease as a
major health concern for

women~

and many women go undiagnosed and under-treated for

heart disease. Moreover, many lack the knowledge to identify the onset of heart disease in
women, as there is a general lack of knowledge in the gender-specific differences based

on ri sk factors.
As baby boomers age, the ratio of females having cardiac episodes compared to
males has expanded. One in two women in the United States wi]] die of heart disease or
stroke. Health issues such as obesity, addiction, depression, diabetes and smoking-all of
which are triggers for

MIs~are

affecting females more so than males. But MI in women

is often difficult to diagnose due to the nature of their presenting signs and symptoms
(Poon et a1.., 2012; K.

Schenck-Gustafsson~

2009; Shaw et a1.., 2006).

In years past, many patients went undiagnosed, especially

fenlales~

due to the

dissimilar signs and symptoms of MI. Furthennore, heart attacks were considered to
predominately affect the male population. The delayed diagnosis and treatment of MI in
females may have increased the morbidity and mortality rate in females.
As technology has

improved~

and tests are nl0re accurate and readily available,

health care professionals have more tools at their disposal, and are able to provide better
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diagnosis and administer more appropriate and timely treatment compared to past
decades. This is perhaps one reason why there's been an increase in the number of
females diagnosed with heart disease. On the other hand, it may also be due to the
increased baby boomer population and the rise of secondary risk factors associated with
each person (Backus et aI., 2010; Brannstrom, Hamberg, Molander, Lovheim, &
Gustafson~

201 1; Collins, 2011 ).

As the population continues to age and more people require medical care, the
overall health care system is in jeopardy. This will put a financial strain on a system that is
already struggling in today's turbulent economic environment. Over the next several
decades hospitals will likely struggle to accommodate and adequately handle the increased
number of emergency room visits. Constraints among hospital personnel and facilities
may also impede the health care system's ability to correctly diagnose patients presenting
with signs and symptoms of an AMI. Timely and accurate resuhs will be critical for
quality outcomes.
The situation presented is the increase in people acquiring medical care is not
anticipated to decrease in the near future.

Technological medical advances have assisted

in the avera)) populations' longevity which will most likely constitute individuals having
one or more risk factors associated with heart disease. The major prob1em is the
disparities within the female population related to the onset of myocardial infarction and
the correct diagnosis in the early stages. Females are at a greater risk of having two or
more comorbidities as compared to males. Females are more prevalent for the disease of
diabetes and they are often considered obese. Often females go untreated when presenting
to the emergency department because of the variation in signs and symptoms unlike in the
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male population. The delay in appropriate intervention causes undue increases in
mortality in females.

Etiology of an MI
Myocardial infarction

(MI)~

better known as heart

attack~

is the leading cause of

death in the United States and in developing countries. It occurs when the flow of
oxygenated blood to the heart is obstructed. If this

blockage~

or occlusion, is not

corrected and the flow of oxygenated blood restored., the heart muscles begin to die.
Coronary heart disease (CHO) and coronary artery disease (CAD) are the leading
causes of M I. CHD is caused by the bui ld-up of plaque in the arteries., a condition known
as atherosclerosis. When and if the plaque starts to break apart a blood clot is fanned., and
as the clot enlarges there is a risk of a partial or complete blockage of the coronary artery_
The blockage will decrease or halt blood flow and cause the heart muscle to die. The
blockage can cause chest pain and discomfort, which are categorized as unstable angina
(UA), non-ST elevation myocardial infarction (NSTEMI), or ST elevation myocardial

infarction (STEMI)

(Radke~

P.W. 20] ]).

Myocardial infarction may also present itself as

UA~

in which there is no noted

occlusion and the biomarkers are negative. NSTEMI is indicative of a partial occlusion

and biomarkers are elevated. The STEM I is considered more acute and is due to a
complete blockage of the coronary artery. A patient suffering acute myocardial infarction
(AMI) STEM} requires immediate intervention procedures in order to survive (Chong,
Shen~ Tan~

& Poh, 20] 1 ).

Patients with ischemia mayor may not reveal STEMI on the electrocardiogram
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(ECG). ST -elevations are noted mostly during ongoing transmural myocardial injury. As
described by Maziar Zafari, MD, if the ST -elevation goes untreated and reperfusion
therapy is not perfonned in a timely manner, the STEMI develops Q waves, which is
indicative of a dead zone within the myocardium and is considered irreversible. When the
incjdent goes untreated or under-treated it increases the likelihood of long-tenn
complications as well as other comorbidities (Canto et aI., 2011; Heller,

Babitsch~

Gunster, & Mockel, 2008; Maziar, 2011).
Zafari states the main cause of ACS cases is atherosclerosis, which accounted for
90 percent of the MIs due to acute thrombus and the occlusion of the coronary artery.

This occurs predominantly near or at the branching points of the vessels. Literature from
the National Institute of Health (NIH), World Health Organization (WHO), and the
American Heart Society (AHS) all indicate the MI risk factors include age, sex, family
history, tobacco use, diabetes mellitus,
hypertrigJyceridemia~

hypertension~

hypercholesterolemia,

dyslipidemia., obesity., sedentary

lifestyle~

lack of exercise,

psychosocial stress, poor ora] hygiene., and type A personality. These risk factors are
considered to be non-modifiable and

modifiable~

however the odds of surviving a heart

attack has doubled since 1979 (Pullon, R.20 11 ~ Bot,

Pouwer~

Zuidersma, van Melle, & de

Jonge., 20 I 2; Chong et a1.., 20 II ; Das et a1.., 201 1).

Gender Differences in Heart Disease
Heart disease is the world's leading cause of death. According to the WHO, 17
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million people will die from a MI incident. Each year approximately 1 million Americans
experience a M I. The Centers for Disease Control and Prevention estimate over 400,000
die annually of coronary heart disease in an emergency department or en route to the
hospital. These patients account for 60 percent of the cardiac-related deaths that occur in
the United States
Thelle~

annually~

of which 250.,000 are women (Tonstad, Sandvik? Larsen., &

2007).
Both healthcare professionals and lay people believe more women die from

cancer-related illnesses than cardiac-related diseases, but women are in fact five times
more likely to die from heart disease than cancer (Bhakta et aI., 2011).
Heart disease must be documented and communicated. While both men and
women are at risk if they exhibit factors associated with heart disease., women may be
more likely to suffer an AMI if they have two or more risk factors than men. There
should be an overall desire in the inquiry for improved methods in assessing and
detecting AMI in the female population (Amsterdam & Robinson" 2008).
One of the main disparities between men and women as it relates to coronary
heart disease 1S that women go under-diagnosed and untreated., whereas

men~

historically,

will more likely be accurately diagnosed with a MI based on the traditional signs and
symptoms. These include pressure, burning, squeezing in the center of the

chest~

discomfort in the anns, shoulders, neck., jaw~ stomach and back., shortness of breath"
fatigue~

cold sweats, nausea, and weakness.
Women often have different symptoms., such as pain in the upper back., jaw., or

neck., shortness of breath. flu-like symptoms, nausea, vomiting, cold sweats., fatigue and
general weakness., anxiety, loss of appetite, and averal1 discomfort (Rudnicka,
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Rumley~

Whincup, Lowe, & Strachan., 201 1).
A Berlin study looking at the mortality rate of patients with AMI between 1999

and 2005 indicated that the overall mortality among women was 18.6 percent compared
to 8.4 percent in men. The

study~

which focused on patients in 25 Berlin hospitals, also

indicated that this disparity exists despite the fact that there have been technological
advances in the early diagnoses of AMC along with public health initiatives and
campaigns aimed at both genders.
The study concluded the median age among women was 72 compared to 62 in

men. It also noted that women took longer to receive healthcare once they arrived at the
hospital, even though they presented to the ED and exhibited more risk factors than the
men. Furthennore., the study indicated the women received less aggressive treatment than
their counterparts (Backus et aI., 20 1O~ Blomkalns et a1., 2005).

Rol1ini and Duenas

discussed similar findings in another study that revealed a lack of knowledge of the signs
and symptoms of AMI as wel1 as the delay of women presenting to the emergency
department. Rollini also suggested women are more acute than men upon arrival, and it's
often too late for successful intervention. The prolonged delay from when women first
show signs and symptoms to when they present in the ED increases the likelihood that
irreversible~
Arana~

extensive damage to the cardiac muscle could occur

(Duenas~ Ramirez~

& Failde" 2011; Rol1ini, Mfeukeu, & Modena, 2009).

There are several factors at work as to why there's an increased rate of M I in
women and a postponement of diagnosis and treatment. Women are usually 10 years
older than men when presenting with the first onset of cardiac disease or MI. During their
childbearing years women are unlikely to present with a MI and CHD and many believe
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there is an
However~

element~

known as estrogen, which may protect women from coronary events.

the risk of a coronary event increases drastically among women within

menopausal and post-menopausal age ranges (Gloria-Bottini et

al.~

2009). The incident

of M I in women between the ages of 30 to 34 is 2 per million~ and for women 40-44, the
rate increases to 20 per million

(Chakhtoura~

Canonico., Gompel, Scarabin., & PIu-Bureau,

2011 ).
The use of oral contraceptives increases the risk of a MI.

Also~

if the subject

smokes., the incident rate increases after 35 years of age. There are older studies that
indicate there was a reverse or decrease in the number of cardiac incidents from 1960 to
1984, which was believed to have been a result of the first use of oral

contraceptives~

which included progesterone.
Additional research was perfonned to include an Hintended use" claim for oral
contraceptives, and the prevention of heart disease in women who were administered the
honnone. However., the studies seeking to prove the decline of cardiac incidents were
observational, and resulted in questionable findings in lab animals. The Food and Drug
Administration halted the study and progesterone oral contraceptives received the "'black
box~'

warning., indicating they were not to be used for any purpose other than the original

intended claim (Chakhtoura et al.., 2011 ).
Honnone replacement therapy is controversial as the negatives sometimes
outweigh the benefits, and some literature suggests the therapy in and of itself is a
primary indication or independent factor of CHD. Due to the potential negative effects
and associated risk factors., honnone therapy should only be administered when there is
no other option (Idris et aI., 2011).
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Pregnancy is another unique risk factor associated with heart disease in women.
Women who have complicated pregnancies due to preeclampsia and gestational
hypertension are two to three times more likely to suffer from heart disease. In addition.,
women with gestational diabetes are seven times more likely to develop type II diabetes,
which relates directly to heart disease. Thi s may be due to the fact that women on average
live longer than

men~

and the complications associated with a complicated pregnancy

may be independent of age and other comorbidities (Skilton et aI., 20 11 ~ Wenger, 2011 ).

Epidemiology of Heart Disease
Risk factors leading to heart disease and AMI among both men and women can be
non-modifiable and modifiable, based on behavior. Many of the risk factors may be out
of the control of the individual., such as family genetics, age and race. However, race has
not been proven to be independent of other risk factors (Backus et a1.., 2010).
Factors considered to increase the risk of a cardiac incident that can be modified
by the individual include

smoking~

obesity.,

depression~

alcohol and illegal drug intake,

exercise, hypertension, diabetes, healthy diet, and high cholesterol levels.
The European Prospective Investigation into Cancer and Nutrition (EPIC) in
Heidelberg is one of the largest cohort studies about what kind of impact diet and
lifestyle have on chronic diseases. Subjects for the study, which included men from 40 to
64 and women from 35 to 64, were recruited over a four-year period. The subjects were
provided a questionnaire about receiving a diagnosis of M I or stroke, along with other
questions about education levels and occupation. The study detennined that male and
female subjects with lower levels of education and job status suffered more MIs and
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strokes compared to subjects with higher education levels and more professional
occupations (Braig et

a1.~

2011).

Epidemiological studies have also observed in subjects a connection between
social economic and social demographic factors and obesity rates. Obesity is a major
public health concern. OveralL, 68 percent of the United State's population is considered
overweight or obese. A prominent tool used to measure obesity is the body mass index
(BMI) plus the Waist Circumference (We) and the Waist to Hip Ratio (WHR) are other
methods to define obesity as well as detennine cardiovascular risk within many ethnic
groups.

However~

a study perfonned by Akil and Ahn1ad and the relation of obesity and

CVD in four southern states showed a low association when obesity was calculated on
the WHR. The ability to obtain the BMI is more easily achieved than the
and is considered a reliable indicator.
considered

overweight~

we

or WHR

Subjects with a BMI greater than 25 are

while a 8MI of 32 or more is considered obese. Data were

obtained from the Centers for Disease Control and Prevention's (CDC) Behavioral Risk
Factor Surveillance System (BRFSS) (Lockyer, L.,2005).
Obesity is becoming increasingly prevalent within the U.S. population, and social
demographic factors playa big role in this trend among both adults and adolescents
(Braig et aI., 2011 ~

Akil~L.

1997~Gafarov~V.V.

2011).

2011 ~ Ahmed,W.A. 2011; Grace,S.L.

2005~

Jonas,B.S.

A National Longitudinal Study revealed that adolescents who lived in households

where the parents didn't have a high school education were more likely to be overweight
or obese .Obesity rates also differ greatly between males and females in different ethnic
groups. For

instance~

among the black population with a low education level, 45.4

19

percent of the women were
education levels among

obese~

blacks~

compared to 16.7 percent of the men. At higher

28 percent of the men were obese., compared to 31

percent of the women (Braig et a1.'\ 2011; Brannstrom et aI., 20 II).
Within the white population,\ there was little overall difference in the obesity rates
between men and women with the same levels of education. It's estimated that between
60 to 80 percent of blacks,

Hispanic~

and whites are

overweight~

and 30 percent are

obese. The continued increase in the obesity rate is expected to result in an increased
number of vascular and heart disease cases, as well as escalating healthcare costs
(Iakovlev, Golofeevskii, & Sotnikov., 201 O;Abstracts of the fourteenth congress of chest
pain centers.20 11 ~ Chong et a1.., 201 1).
Obesity is a major risk factor for fatal heart attacks., and has been associated with
other risk factors such as diabetes and hypertension. However, a study conducted in
Scotland indicated obesity could be an independent factor as well. Inflammation has been
a serious factor in fatal MIs and it is now believed obesity is an inflammation condition
(Jennifer

Logue~

2011).

One of the major impacts of heart disease among both overweight and obese
individuals is diabetes mellitus 11 (DM2). Diabetes mellitus is a chronic disease with
many complications if not treated appropriately. The complications include
hyperglycemia~

hypertensjon~

coagulation abnonnalities and endothelial dysfunction. While diabetes

does not discriminate., the disease is three to five times more prevalent among women.
The disparity in the incidents of heart disease among men and women of the same age is
linked to endogenous sex hormones such as estrogen and progesterone., which influence
the vasculature (Vaccarino et aI., 201 1 )).
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Among premenopausal women with diabetes, the post-mortem reveals the
coronary arteries resemble a postmenopausal female without diabetes. There is a direct
relation to endogenous sex hormones and diabetes. Women with diabetes in their
childbearing years are more at risk of heart disease and less protected compared to
women of the same age without diabetes (Meyer,

Clegg~

Prossnitz, & Barton, 2011).

The intervention and treatment of patients presenting to the emergency room is of
utmost importance, particularly among women presenting with multiple risk factors such
as diabetes and hypertension. The patient, especially the STEMI patient, can be treated
with primary percutaneous coronary intervention, triple-anti-platelet therapy, and
thrombus aspiration. When treated properly, the short ischemic time was associated with
better myocardial reperfusion and decreased

mortality~

whereas if STEMI diabetic

patients are treated more than five hours after onset., the mortality rate increases
(F okkema et al.~ 201 1).

The need to understand the signs and symptoms, detennine a diagnosis, and
administer aggressive treatment is very important in both men and women. One study
indicated that even if females are diagnosed correctly, they are often less aggressively
treated. The higher morbidity and mortality rate among women can be explained to some
extent by the fact that diabetic women are receiving aggressive risk-factor l11odifications.,
which are decrease in aspirin usage, less frequent screening and treatment for
dyslipidemia, as well as treatment for hypertension. This is mainly due to the biological
variation in cholesterol

levels~

HDL, coagulation and platelet in associating with the

micro- and macro-vascular complications of dysfunction and imba1ance and the mean
blood pressure differences (Brannstrom et aI., 2011; Jensen et aI., 2011 ).
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Concerns over the early and late onset of diabetes mellitus and the overall effect
in the outcomes of heart disease illustrate some interesting findings. A study was
perfonned on subjects with early onset and late onset of diabetes. Both types of subjects
exhibited a greater risk for heart disease; however, the ones with the late onset were at
greater risk (Nunnohamed & Kitas, 20] ] )).
Emphasis has been placed on the risk factors that heighten the potential for
diabetes and increase mortality in men and women. However, women with diabetes are at
least three times more likely to die from a MI both during the earlier and later years of
life

(Knopp~ 1997;Wannamethee~

Shaper, Whincup, Lennon, & Sattar, 20] ]).

There are nine risk factors that are of particular concern when it comes to M Is and
the mortality rate of patients with heart disease. One is the psychosocial factor, such as
depression. Depression is a medical illness that causes a persistent feeling of sadness and
a loss of interest. Depression does not only affect the mental being but the physical being
as well. Both men and women with depression often go untreated due to the stigma
associated with the disease, and in some cases a lack of motivation to seek treatment is in
itself a symptom of the disease

(Schenck-Gustafsson~K~ Anderson~A.,

201 O;Canto et

a1.~

201 1).

The correlation between cardiovascular disease and psychosocial conditions has
been under investigation for years, and it has been detennined there is a direct
relationship between the two. Proietti and Strik both indicated adverse emotional stress,
personality traits, chronic stress, and social behaviors trigger both depression and anxiety.
These psychosocial factors can induce myocardial episodes mainly due to the effect of
stressors on the sympathetic nervous system and hypothalamus neuroendocrine axis. This
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is indicative of the heart and brain traveling along the same path and the effect of one
over the other (Laskey et aI., 20 1O~ Proietti, R., Mapellli,

D.~

Volpe, B., 20 I I; Strik et al..,

2000)).

The strength of the brain and mind is linked to the interconnectedness between
depression and MIs. Severe depression if not medically treated can increase the patient's
risk of a cardiac event if the depression initiates the onset of cardiac arrhythmias.
Abnormalities in heart rate., increase levels of inflammatory markers, platelet activation
and plasma norepinephrine are all indicators of the potential risk associated with a
cardiac episode (William Whang, MD, Laura D. Kubzansky, PhD., Ichiro Kawachi., MD,
PhD, Sathryn Rexrode, MD, 2009).
During the onset of a cardiac event, many patients don't realize they've exhibited
psychosocial behaviors., which may be due to an unchanging social and economical
status within their lives. Often depression has become ever presence in the person and
their ability to recognize critical cardiac symptoms are diminished. Depression can be a
chronic condition and can manifest itself in both man and women; however women
appear to have a higher incident which can obscure a cardiac event due to mimicking
symptoms of both diseases. (Bot et

a1.~

2012).

Post MI depression can develop during the first 18 months following the incident,
and occurs in 15 to 30 percent of the cardiac patients both men and women. These
patients should be assessed after the incident and before leaving the hospital for any signs
or symptoms of depression. If the patient does not exhibit any symptoms of depression,
they should be made aware of what to look for and encouraged to do a weekly selfassessment. The importance of reviewing the clinical profile of a
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patient~

especially with

women, may be a preventive measure to ensure improved one-year outcomes. If the
subject goes undiagnosed or untreated., there is an increase in morbidity and mortality
(Strik J., Honig A.,

Maes~

M.'\ 2001).

There are three phases that can assist in providing the appropriate treatment for
women who are at risk of suffering depressive episodes. The first is the diagnostic phase,
during which the healthcare professional should ask the patient questions about previous
and present stress factors as well as stress symptoms. The healthcare professional should
use this infonnation to make a diagnosis. A useful resource for this phase is the Beck
Depression Inventory., which provides scores as to the severity of the depression
(Francois Lesperance, Nancy Frasure-Smith, Mario Talajic, & Martial Bourassa,\ 2002).
The second phase is educational, and it's designed to increase a patient's
awareness and understanding of how

stress~

anxiety and other psychological factors are

related to cardiac health ( Lesperance")F. 2002;

Laskey~Warren

20 10).

The third phase is intervention and secondary prevention. This phase is intended
to initiate and support improvements in the patient's lifestyle and psychosocial
environment at home and work (Heart Failure Executive Committee et

al.~ 2008~

Schiele

et a1.., 2011 ~Francois Lesperance et a1.., 2002))
One study out of Spain reviewed the number of MIs in relation to seasonal
variations, but was not able to consistency correlate the variables to support the theory as
to the relationship of seasonal changes and deaths due to ischemic heart disease
(Dominguez-Rodriguez & Abreu-Gonzalez, 2010).
Many patients undergoing a cardiac event often obtain rehabilitation services to
improve psychological health, restore self-confidence" lighten anxiety
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levels~

and to

increase the likelihood of participation in nonnal daily living. When the psychosocial
behaviors are modified and treated, the mortality rate is more likely to decrease.
However, the female population is less likely to obtain the necessary services, such as
cardiac rehab, and is more likely to drop out if they do seek services. This is due to the
increased number of responsibilities women are now taking on as they juggle families
and careers (Schenck-Gustafsson,K,

Anderson~A . .,

2010; Veronesi et a1., 2011).

A study in Iran stated that depression was independently associated with an acute
myocardial infarction, however other studies have shown that while it may be
independent, depression is directly linked to other risk factors such as hypertension,
diabetes, and inflammatory diseases (Hashemian,F. 2006; Jonas,B.S. 1997).
The mental state of individuals may cause negative behaviors such as overeating,
smoking, self-prescribing medications, and substance abuse. Many individuals, as in Iran,
are directly impacted by stressful living conditions brought on by war and political

unrest. These factors are difficult to change and may bring about fee1ings of impending
doom (Yary et aI., 2010).
Most of the studies used the same baseline variables for cases and controls as well

as categorical variables based on depression levels. All literature indicated a direct link
between depression and cardiac events, and that the outcome measures associated with
depression if not treated or diagnosed will have an overwhelming effect based on the

increase in morbidity and mortality (Apostolopoulos et aI., 2011; Bot et aI., 2012;
Scherrer et aI., 2012).
Smoking is another contributing factor of heart disease. The Centers for Disease
Control and Prevention (C'DC'P) reported in the first half of 2010 that in the United States
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22 percent of men and 18 percent of women smoked tobacco.
The use of tobacco has decreased by nearly half since the 1960s due to antismoking policies and public health campaigns. Tobacco has been linked to cancer, heart
disease~

hypertension, chronic obstructive pulmonary disease (COPD) as well as other

serious health related diseases. In 2008'1 smoking was associated with 8.1 percent of
deaths in the United States. There is a statistically significant increase in the number of
individuals who smoke tobacco and who have cardiovascular diseases compared to those
who don ~t smoke (Schroetter,

S.~

& Peck, S.,2008).

There were four related studies comparing states that participated in smoking
ordinances and the impact on MI and asthma-related hospital stays. The four states all
had positive outcomes related to hospital discharge summaries for the diagnosis of MI
and asthma from before and after the non-smoking ordinance. The results showed a
statistical1y significant decrease in incidences of AMI and asthma compared to the nonstate and in-state residents (Asthana et al., 2012).
A prospective study was perfornled based on 600 subjects and the 1ong-term
effects of smoking and smoking cessation based on markers relating to cardiovascular
disease. A treadmi 11 stress test was performed and it suggested that individuals abstaining
from smoking might have an improved prognosis from CVD compared to smokers
(Underner & Perriot" 20 I I).
There are also the consequences of secondhand smoke, which is believed to
influence CYD and the onset of AMI. Individuals exposed to secondhand smoke are at
the same risk as smokers themselves (Veronesi et aL,! 2011). A study by TheIle (2011 )
indicated that in looking at both men and women who smoke, wonlen are at a greater risk
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for a MI. (308 Theile, Oag S. 1976)
The research and literature reviews all agree the effects of smoking are directly
related to an increase in heart disease and higher morbidity and mortality rates in both
women and men. The roles of socioeconomics and education levels are directly related to
the smoking and non-smoking populations as well. The less educated a population is, the
more likely it is to smoke. Less educated individuals are less likely to modify their
behavior~

even though there have been extensive campaigns concerning the negative

effects of smoking (Underner & Perriot, 2011 ).
Some studies show moderate alcohol consumption, most notably wine, can have
positive health benefits, such as lowering the risk of heart disease and decreasing
mortality (Lindberg,M.L.

2008~

Crouch,Rosanne 20 11 ~ Lindschou Hansen,]. 2011 ).

But alcohol and excessive drinking is also associated with

hypertension~

which

has a considerable negative effect on cardiac health. Hypertension is also a serious public
health issue in developing countries. Hanson et al (2011 ) performed a study to examine
the effects of whether middle-aged men and women with hypertension who consumed
moderate amounts of alcohol were at a greater risk of ACS than those without
hypertensi on.
The study's conclusion indicated there was not an increased risk of ACS in either
the hypertensive or non-hypertensive subjects.
exceeded moderate levels of alcohol
mortality (Lindschou Hansen et

al.~

However~

consumption~

2011).

Signs and Symptoms of a M I.
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if subjects with hypertension

there was an increase in ACS and

ACS is common in both men and women. The onset of ACS in women often
appears 10 to 15 years later than men plus the signs and symptoms of women differ
(Maas~ Lagro-Janssen~

& de

Based on literature

Boer~

2011).

reviews~

among women are chest pain (78

the most common signs and symptoms of ACS

percent)~

unusual fatigue (67 percent)'l breathing

difficulties when exercising (58 percent), and radiating pain in the back, jaw, and ann (50
percent). The less common symptoms are feeling flush., or cold sweats (40 percent),
dizziness (39 percent), and nausea (38 percent).
The prodromal or early signs and symptoms of Ml as stated by women are fatigue
(70 percent), anxiety (31 percent), chest discomfort (37 percent), along with indigestion,

shortness of breath, and sleeping difficulties (40 percent) (Waller, 2006) (Sharobaro,
Zhenchevskaia., & Ivanova., 20 I I).
In

2004~

the American Heart Association (AHA) offered practical guidelines

based on evidence and communicated the unique risks women confront and the
importance of recognizing signs and symptoms independently. Since 2004., several
campaigns have helped increase public awareness about heart disease. The most
recognized campaign is the "'Heart Truth,'I' which is signified by

~"wear

red

day~~

during

February to express the ongoing need for education. Over the years the campaign has
been updated and revised') including in 20 II,) when IoIoEffectiveness-Based Guidelines for
Prevention of Cardiovascular Disease in Women-20 II " was introduced.

Again~

guidelines are recommendations based on evidence and clinical observations

the

(Thanavaro~

Thanavaro; & Delicath, 20 I O~O~Keate-McCarthy).
Norwegian authors provided statistics on CHD incidences among both men and
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women based on age and sex. The study showed an increase of incidences in women
compared to men, much like studies in Scotland and the United States. The Finnish
authors suggested this trend was due to the limited awareness of CHD in women and
diagnostic

sensitivity~

as well as pathological differences associated with more fatal

outcomes in older and younger women. The studies noted CHD is a dynamic process and
is influenced by lifestyle changes, social conditions, and external factors. These trends
should increase the demand for public health awareness of both younger and older
females. (Backus et aI.; 20 1O~ Duenas et a1., 20 11 ~ Heller et a1., 2008; Jankowski et

20 I 1~ Thanavaro et a1., 20 1O~

Legto~

H.,

Lehto~ S.~

&

Havu1inna~

al.~

A.,2007).

In exploring diagnostic experiences in women relating to ACS and MI several
themes emerged, including that the women were unaware of the

condition~

did not seek

treatment, or experienced frustration and anger when they did due to lack of interest from
the healthcare professionals. This inadequate diagnosis also plays a role in increased
cases of morbidity and mortality. This is mainly due to the multiplicity of symptoms that
were not reported or recognized as cardiac in nature. Women often have a higher rate of
functional disability and a lower prevalence of obstructive CHD as noted by coronary
angiogram

(Lee~

Betsy

Chang~

Lichtman et a1., 20 1O~ Mosca"l

Anna Marie

Matsuura~Asako

Barrett~Connor~

&

Wenger~

C. & Marcoon, 2011;

20 11 ~).

The global perception pertaining to women and heart disease is still a problem.
Studies reveal women still lack the knowledge to make infonned decisions to better
prevent heart disease and related risk factors.
Breast cancer is currently identified as the leading cause of death in females
between 25 and 44. Women 65 and older indicated a lack of infonnation on heart disease
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and 70 percent have never spoken to their physician regarding risk factors.
Interestingly enough, 44 percent of all women surveyed did not believe they
would suffer an

AMI~

and they all rated themselves as being educated on heart disease

(Mosca et aI., 2011 ).

Another study interviewed a mix of white, African American, and Hispanic
women based

all

age. According to the literature, 61 percent of the respondents thought

cancer was the greatest health problem among

wonlen~

and only eight percent declared

heart disease to be an issue. Only 16 percent of women of age 25-34 recognized heart
disease to be the leading cause of death, and only four percent believed it was the greatest
health problem (Gutierrez,N. 2011 ~ Hamner,]. 2008; Crouch,R.,2011;
Framinghamheartstudy).
When the data was separated based on ethnicity., it was revealed that among all
groups, the majority still considered cancer to be the leading cause of death~ smoking and
immunodeficiency disease were rated next. There was also little difference in the
subjects ~ ability to make infonned decisions concerning heart disease within the different
age and ethnicity groups.
When asked what the most common symptoms were for women, 67 percent
indicated chest pain and 10 percent indicated shortness of breath~ ann

pain~ tightness~

nausea. The younger women associated an increase in blood pressure to heart
whereas all cited excess

welght~

and

disease~

lack of exercise~ smoking, and high cholesterol as

contributing to the disease. The percentage was low in linking menopause and heart
disease. The study also showed African Americans communicated with their physicians
more often than whites or

Hispanics~

and only 14 percent of the women between ages 2530

34 ever talked to their doctors (Mosca,L. 20 11 ~ Mieres,J .H. 2011).
A national survey indicated 60 percent of women between ages 25-34 received
information on heart disease, compared to 82 percent of women between 45-64, and 71
percent of women 65 and older. The leading media source for delivering the infonnation
was magazines, according to the survey, with 24 percent of the respondents saying they
received information from television, while 18 percent gathered infonnation from health
professionals. Women 65 and older noted the newspaper as their main source of
infonnation. Ethnic groups and younger women were the largest consumers of magazines
(Mieres et aI., 2011 ).
It is not unusual for women, as well as health professionals, to acknowledge the
various pathophysiologic mechanisms related to females. The diagnostic model of chest
pain is indicative of the focus of significant obstruction within the large coronary arteries.
The disparities lie in the lack of understanding. The model of chest pain in females may
look at the endothe1ia) dysfunction, estrogen deficiency., and abdominal nociception in
understanding the issues of microvascular angina (MY A)
(

Vaccarino~Yiola

2011 :Tsang,Teresa S.M.

2000~Nugent.,Lynn

2011 ).

Again, increasing knowledge of the pathophysiologic mechanism among women
and its relation to heart disease is of great importance. Current diagnostic strategies
stratify chest pain according to cardiac and non-cardiac utilizing measures aimed at
underlying etiologies. Gender differences can make this complicated and can lead to
misdiagnosis or mismanagement. Some indicate the disparities are due to how women
report or cope with chest pain., but more data is pointing to the pathophysiologies such as
MV A. MY A represents coronary

obstructions~
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which is significant to CAD., non-

obstructive chest pain., and these women may be triaged incorrectly and go untreated.
However~

women were more frequently diagnosed with AMI from the 1990s to

2002. The reasons for this could be more educated health professionals, improved
patient

infonnation~

testing~

and improved national guidelines. Many believe breast cancer is the

leading cause of death in women which is often associated with ongoing campaigns
concerning breast health and the need for preventative screenings. The question
remains: Is enough focus, energy, and time being committed to communicating to women
the risks and disparities associated with heart disease (Daugherty et
Chang~

a1.~

2011; Lee, Betsy

Anna Marie Matsuura.,Asako C. & Marcoon, 2011 ; Lichtman et aI., 201 O)?

Effects of Population Changes on MI
The number of patients over the age of 65 will triple between 1980 and 2030.
Persons born between 1946 and 1964, called

~'baby

boomers," started turning 65 in 20 II.

This increase in the aging population wil1 magnify the stress on the United State's
healthcare system, impacting the industry for decades. Not only are the baby boomers
reaching 65, but there is also an lncrease in life expectancy in both men and women.
Longevity is not necessarily directly related to quality of life due to comorbidities which
many of these individuals possess. The American Heart Association (AHA) believes this
is just the beginning, and over the next decade the percentage of persons having two or
more diseases will increase. C"'urrently healthcare costs and accessibility are under review
to ensure proper healthcare is provided to everyone.
The demand for increased health services wi]] exacerbate the need for wellness
and preventive care. It is estimated that 14 million people, or I in
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4~

will have diabetes,

and at least half of those will have arthritis. Moreover, at least 21 million people, or 1 in
3, will be obese.
Literature reviews indicate more individuals of the current generation will die of
heart disease at a greater rate than previous ones. Literature suggests the population is
now less likely to smoke, however heart disease remains a problem. The other concern is
the ongoing necessity for healthcare and the essential demand for healthcare providers.
The need for healthcare is increasing and the caregivers are aging out faster than they are
being replaced. This means signs and symptoms are more likely to go undiagnosed or be
incorrectly treated, and result in increased morbidity and mortality (Kihara'\ 201 1; Mieres
et

a1.~

2011 ).

Intervention for MI
Cardiac intervention is the same for women as it is for men.

However~

intervention measures are not perfonned as frequently with women. The most routinely
recommended treatment for primary prevention of cardiac disease is aspirin. Aspirin is
often prescribed for men, while women are less likely to receive it due to the
contraindications. There is a greater risk for gastric-bleeding among women, and it is
recommended aspirin only be prescribed on an individual basis.
There may be some relevance as to the reasons the incidents of AMI have plateau
or decreased in men and not in women. There are also the detennination and prognosis
factors associated with the guidelines in detennining when an intervention measure
should occur in the cardiac patient.
Women and men differ in the ECG and vasodilator stress test calculated
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outcomes. Women have a lower prevalence of obstructive coronary artery disease than
men., which in part is due to the micro-vascular issues. Men more often appear with large

obstructions during the testing phase and are more likely to receive intervention
procedures. Women will go untreated or receive a lesser intervention, which will increase
their overall mortality and morbidity. Evidence-based intervention decisions should be
based on many factors such as

symptoms~

risk profiles, and testing measures. There is

also a decrease in beneficial therapies and rehabilitation referrals with women due to a
lack of knowledge and extensive damage prior and post MI (Nugent.,L. 2011).
Thrombolytic era and patient management provided evidence of increases in
women less than 65. Younger women were less likely to be thrombolytic than men their
same age.

However~

due to various educational campaigns supported by the National

Heart, Lungs, and Blood Institute, a division of the U.S. Department of Health and
Human Services, awareness has increased overall. In 1997, 30 percent of the women
were aware. Awareness increased in 2009 to 69 percent, the highest level to date. The
level of awareness decreased the fol1owing year to 62 percent. The campaign has lost
some of its momentum and the percentage is at a level that nlay put some women in
jeopardy_
While not perfonned as often to women as compared to men., more invasive
interventions such as cardiac catheterization, cardiac angiogram, and percutaneous
coronary intervention will continue as heart disease risk factors increase and awareness
decreases among women.
Two out of three women with heart disease are projected to have more than one
comorbidity, and the potential of healthcare providers to improperly diagnose the
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condition increases the likelihood of a myocardial incident. Laboratory testing is an
important modality in the basic cardiac workup. Laboratory testing can be performed at
the patient's bedside with a blood analysis to include cardiac biomarkers to detennine the
presence or absence of a myocardial

infarction~

early or late complications, and the

prognosis (De Luca et a1., 2010: Gutierrez, 20 I 1: Jensen et aI., 2011; Johnston, SchenckGustafsson, & Lagerqvist, 201 1).
Laboratory testing is also useful in detecting comorbidities and assisting in the
care of the patient. The ACe and AHA state the biomarker troponin is the criterion
standard for defining and diagnosing myocardial infarction. A positive troponin is
indicative of a myocardial infarction and is measured in most EOs. A positive troponin is
an independent indicator of increased risk of a cardiac event. The administration of
therapy with LMWHs and/or OP lIb/IlIa inhibitors appears to bestow the most advantage
for patients with elevated cardiac troponin levels according to the evidence in the PRISM,
PURSUIT, and T ACTICS-TIMl 18 trial. Laboratory testing is not all inclusive of early
detennination of an M I when various other conlorbidities exist and other modalities must
also be considered (De Luca, G., Gibson, C., & Gyongyosi, M. (201 O):Veronesi,G. 2011;
Gafarov,V.V. 2011).
Cardiac-related incidents and deaths among males and females are a major public
health issue. The AHA established evidence-based guidelines and Door-to-BaUoon
(D28) national standards. Many medical centers in their strategic objectives initiated the
established quality measures to include ED
(eCL), emergency medical services

staffing~

(EMS)~

cardiac catheterization laboratory

cardiologists, phannacists, and others in

order to seek and gain the chest pain center accreditation. This was also due to the Center
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for Medicare/Medicaid Services meeting their specified core measures or STEM! criteria.
The overall goal is to diagnose and start treating the cardiac patient within 90
minutes. Since the start of D2B there have been great improvements in patient outcomes.
The need for a proper triage process within the ED is essential for both genders, however
an understanding of the differences in the pathophysiology in females is of utmost
importance in administering treatment according to the national standard guidelines
(Heart Failure Executive Committee et aI.,
Georgiadou, & Voudrls,

2011~

2008~

Sheridan et aI.,

Johnston et aI., 20 11; Sbarouni,

20II~

Collins, S. (2010).).

There are both retrospective and prospective studies alluding to outcomes of men
and women upon presenting to the ED with chest pain and the statistical data concerning
the mortality rate between the two. A Gennan study analyzed data from pre-hospital, first

day of hospitalization, and days 2-28, which revealed the first-day mortality rate for
women was significantly higher than for men, although only slightly increased during the
later phases. Another European study indicated some of the same findings, however it
indicated this was probably related to the increase in comorbidities in women, such as
diabetes mellitus and
Fabijanic,D.

2006~

hypertension~

as compared to men ( Bush,N. 20 11 ~ Chong.,E. 201 1~

Flores-Mateo,G. 20 II ~ Kostis W J. Deng Y. Pantazopoulos JS.

Moreyra AE. Kostis JB. Myocardial Infarction Data Acquisition System (MIDAS 14)
Study Group 20 1O~ Schiele.,F. 2011 ).
There is evidence due to heart awareness national campaigns and other public
health initiatives concerning cardiac disease that women are more aware of the signs and
symptoms of a heart attack or M I, and are more proactive in presenting to the ED. From
1990 to 2002 there was an increase in women diagnosed with ICO-9-CM 410.
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Myocardial infarction is the leading cause of death in the United States. The
etiology derives from a bui Idup of plaque in the

arteries~

or atherosclerosis, and when the

plaque begins to break apart a clot is formed. There is a high risk of the clot enlarging
and causing a partial to complete occlusion of blood flow to the heart. The decreased
blood flow to the heart affects cardiac oxygenation which causes the heart muscle to die.
Subjects often have signs and synlptoms consisting of chest pain and discomfort. An
acute myocardial infarction is diagnosed as UA, NSTEMI, or

STEMI~

and requires

prompt diagnosis and treatment for patient surviva1. Risk factors associated with heart
disease are considered non-modifiable and modifiable (Radke, 201 l; Waller,

2006~

Wang

et a1., 20 12~ Yiadom, 20 II ~ Yiu et aI., 2012).

Sunlmary of Issues Identified in the Literature
Population changes expected over the next decade will result in more women
presenting to ERs with an AMI within the US.

However~

symptoms of MIs in women

nlay be quite different from those presented by men. Timely use of new medical
interventions can prevent or limit severe damage to the heart.

However~

women may be at

risk for delayed diagnosis because many of their presenting AMI symptoms are not part
of the nonnally accepted indicators of AMI. Use of new laboratory tests n1ay improve
early diagnosis of AMI in women, but the use of such tests will add to the cost of care.
Thus~

discussions of changes in practice guidelines to expand the use of testing to screen

for AM I in women requires us to have estimates of the magnitude of the increase in the
population for which these tests are used, and the number of women who may have the
potential for benefiting from increased preemptive testing. This study wil1 provide
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scientific data needed to infom1 the discussion of expansion of testing for AMI in women
presenting in the ER.
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METHODS

This study used a retrospective analysis of archival data on hospital discharges
from three states to examine the 1O-year trend in hospital admissions of patients with a
primary diagnosis of AMI" to document rate changes by gender over time. The research
questions examined are:
I) Have hospital admissions for MI in women increased over the last ten

years~

compared

to the number of admissions for men?
Hypothesis: Women constitute an increasing proportion of AMI admissions over

time~

controlling for age and racial risk factors.
2) Are women more likely than men to have comorbid conditions of diabetes and obesity?

Hypothesis: The percent of women with an AMI with obesity and diabetes risk factors
has increased more than the percent observed for men.
3) Are women admitted to a hospital with an AMI in 2010 more likely than men to have a
comorbid diagnosis of chest pain. muscle strain. heart bum. gastric reflux disease or vague

complaints that could obscure a diagnosis of AMI than men?
Hypothesis: A higher proportion of women than men with an AMI have a comorbid
diagnosis or a complaint that could obscure AMI signs and symptoms.

Hospital Discharge Data
State Hospital Discharge Record data sets from Arizona

(AZ)~

Florida

(FL)~

Maryland (MD) for the years 2000 through 2010 were examined. These states were
selected due to geographical location within the United States based on the diverse
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and

population and the complete hospital discharged records from at least 200 1 to 2010. We
extracted all hospital admissions with a primary diagnosis of ICO-9-CM 410.0 to 410.92.
The ICD-9-CM is the International Classification of Diseases, Ninth Revision, Clinical
Modification (ICD-9-CM) is based on the World Health Organization's Ninth Revision,
International Classification of Diseases (ICD-9). ICO-9-CM is the official system of
assigning codes to diagnoses and procedures associated with hospital utilization in the
United States. ICO-9-CM 410. 0 to 410.92 is to identify Acute Myocardial Infarction.

Presence of Diabetes and Obesity and Other Risk Factors
Each hospital admission record was examined for the presence of diagnosis codes for
diabetes (ICD-9 250.xx) and obesity (ICD-9 codes 278.xx, 259.9 and V85.xx). We
compared the likelihood of AMI patients with a comorbid diagnosis of diabetes and
obesity being female using a logistic regression to predict the presence of comorbid
diagnoses of obesity and diabetes by gender.

Statistical Analysis
We used multi variable logistic regression analysis to predict females' gender for
admissions for AM lover time. This approach avoided the necessity of calculating annual
population rates for AMI weighted by the

state~s

population of adult males and females

over age 50 for each year. This is an important innovative application of regression that
avoids the need to use inter-censal state population predictions to calculate a population
rate for each study year.
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RESULTS
The examination of hospital discharge data from the years 2000-2010 included three
states; Arizona, Maryland, and Florida. We examined a total of 781 ,995 discharges with
a principal diagnosis of AMI, as well as the trend in discharges over time based on the
presence of a primary diagnosis of AMI in the electronic summary derived from the
UB04 Hospital Discharge Record. A decreasing trend in the number of MIs was

observed over time. In year 2000

Florida~s

rate was 55343 compared to 44278 in 2010, a

decrease of 20% as compared to Arizona, which in 2000 had 11130 patients diagnosis
with MI with only a 1% decrease to ] 0985 in 2010. Maryland had the largest decrease of
30 0/0, however due to lack of discharge data for them in 2000 the percentage was based
on 2001 of 14109 and in 2010 there was 9889 patients with the discharge diagnosis of M I
as noted in table 1 below. The average decrease for the three states from 200 I to 2010
indicated a 200/0 decrease of MIs.

Furthennore, the only year with an increase number of

MI discharges was in 200 1. Both Florida and Arizona Increased by less than 1%;

Maryland was excluded due to lack of data for year 2000. The results of this descriptive
analysis are presented in Table 1 below.
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Tabl e 1 N urn bera fO'lSC h arges
Year
Florida

MI']n FL , MD an d AZ firom 2000 th rough 2010
Maryland
Arizona
Total in study

.h
WIt

2000

55343

NA

11130

66473

2001

55586

14109

11704

81399

2002

54977

13908

10752

79637

2003

54412

13984

10752

79148

2004

52999

12645

112] 3

76857

2005

50883

11888

10815

73586

2006

47549

2730

10643

60922

2007

46307

10171

10560

67038

2008

46155

10183

]0854

67192

2009

43748

10174

10658

64580

2010

44278

9889

10985

65152

The number of patients with the discharge diagnosis of AM I decreased over the tinle
of the study. This is especially important to note because the adult population over age 65

in the three states increased from 4,074,743 in 200 1 to 4,848,)075 in 2010 over that time.
However, as the number of patient AM I discharges decreased the percentage of males
and females stayed relatively the same from 2001 to 2010. Florida percentage of females
with AMI was 400/0 during this period, whereas Arizona had 36%-380/0 variability
distributed from 2001 to 2010. Maryland had the highest percentage of females
compared to the other two states from 41 % to 44% in Tab1e 2.
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Table 2: Percent ofMI admissions for men and women with MI in FL, SC and MD from
200 1 through 2010.
AZ
MD
AZ
MD
FL
FL
Year
Men
Men
Women
Men
Women
Women
36%
60%
640/0
40%
440/0
560/0
2001

2002

40%

600/0

42%

58%

370/0

630/0

2003

40%

600/0

43%

57%

380/0

620/0

2004

400/0

60%

43%

57%

380/0

620/0

2005

400/0

60%

420/0

580/0

37%

63%

2006

390/0

610/0

41%

590/0

37%

63%

2007

40%

61 0/0

44%

56%

380/0

620/0

2008

40%

600/0

42%

580/0

38%

620/0

2009

39%

610/0

41 %

590/0

370/0

630/0

2010

390/0

610/0

420/0

58%

360/0

640/0

The overall decrease in AM I admissions from 2001 to 2010 in the population based on
the Hospital Discharge Summary does not reflect trends observed for the minority
populations. The African American population has increased as a proportion of patients
with AMI. Mary]and has had the largest increase of 6.7 % as compared to Florida with

2.6%. The rates in Arizona were calculated for

black~

Native American, and Hispanic

populations, because th1s state has a high proportion of Native American and Hispanic
citizens. We observed an increased less than 1% for minority groups in AZ from 2001 to
2010. Table 3 shows that the percentage of African Americans having an AMI is
increasing as a proportion of the tota1 population over time.
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Table 3: Percent increase in number of MI Discharges for African American with AMI in
FL, MD, and AZ from 200 1 through 2010 using 2000 as base Year.
Year
FL
MD
AZ
Black

Black

Black/Native American/
Hispanic

2001

6.61

17.46

1.73

2002

6.91

18.85

l.86

2003

7.83

19.31

2.01

2004

8.20

19.68

2.14

2005

7.89

19.87

2.51

2006

8.02

17.22

2.31

2007

8.42

21.22

2.45

2008

8.76

21.83

2.66

2009

9.24

21.87

2.70

2010

9.45

24.16

2.66

The nlean age based on discharges of all persons with AMI for 2000-2010 in the
three states was 66.7 to 69.8. The nlean age decreased from 2001 to 2010 by 9 months
whh the highest mean in Florida and the lowest in Maryland as in Table 4.
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Table 4: The mean age of patients with AMI based on Hospital Discharge Summary
from Florida, Maryland, and Arizona in 2000 to 2010. There are no data for Maryland in
2000.
Year
2000
2001
2002
2003
2004

2005
2006

2007
2008
2009
2010

Florida
69.8

Maryland
NA

Arizona
67.9

69.8

68.1

67.9

69.5

67.6

67.8

69.5

67.7

68.0

69.6

67.8

68.0

69.2

67.6

68.0

69.0

66.6

67.5

69.0

67.4

68.0

69.1

67.0

67.6

68.8

66.7

67.9

68.9

66.9

67.6

Mean
69.5
69.2
69.7

68.9
69.0
68.8
68.6
68.6
68.6
68.3

68.4

We examined the data for all three states for the process used to diagnose and treat an
ML Specifically we identified each individual discharge record for use of an angiogram,

as indicated by a procedure code of 36.03, 36.09 or 00.66. Angiograms (open or
percutaneous) were rarely coded for hospital admissions with MI prior to 2005. After that
year we observe that women who were admitted with a principal diagnosis of M I were
much less likely than male M I patients to have a record of having recelved an angiogram.
Since an angiogram provldes a definit1ve diagnosls of an M I, thls is an important
difference in the process used for diagnosing MIs in men and women. Because of this
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difference we will control for the use of angiography in the logistic modeling used to
predict changes in the male-female proportions of MI patients over time as noted in Table
5.

Table 5: Percent M I Hospital Admissions in AZ, FL and MD with Angiogram Record by
Year and Gender*
Year
AZ
AZ
MD
FL
MD
FL
Females
Males
Females
Males
Males
Females
<1%
<1%
2000
<10/0
<1%
<10/0
<10/0
2001

<1%

<1%

<1 %

<1%

<10/0

<1 %

2002

<1 010

<10/0

<1%

<1 %

<10/0

2003

<1%

<10/0
<1 0/0

<10/0

<1%

<10/0

<10/0

2004

<1%

<1 %

<1 0/0

<10/0

<10/0

<10/0

2005

10.2%

12.4%

7.2

9.8

7.50/0

10.00/0

2006

42.0%

54.6%

45.8

54.1

32.10/0

43.80/0

2007

41.30/0

52.5%

3l.4

42.0

31.60/0

44.60/0

2008

4 I. 70/0

54.7%

31.7

44.3

32.0%

45.80/0

2009

42.70/0

56.1%

31.1

45.0

35.5%

48.4%

2010

45.30/0

56.30/0

31.0

45.6

36.60/0

49.20/0

*Male vs. female rates p<.OOO 1

The age, race and/or ethnicity of MI patients also varied across time and across the states,
as noted in Table 6. Thus we controlled for age, race/ethnicity in the logistic regressions
used to assess the changes in proportions of women with MI over time. The results of
modeling the change in the proportion of MI patients who are women, controlling for age
and racelethnicity changes are provided in Table 6 below.
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Table 6: Logistic model predicting the likelihood of being female for all admissions with
a primary diagnosis of MI for AZ~ MD and FL from 2000 through 2010.
AZ
AZ
FL
MD
FL
MD

Odds
Ratio
Intercept

Odds
Ratio

Odds
Ratio
-19.4253

-34.1692

-25.1114

Year

0.0156

1.016

0.00829

1.008*

0.011 1

1.011

Age

0.0338

1.034

0.0359

1.037

0.0339

1.034

Angioplasty

-0.2370

0.789

-0.2601

0.771

-0.2477

0.781

Black

0.5453

1.722

0.5574

1.746

0.6220

1.863

Native
American

0.2809

1.324

NA

NA

NA

NA

Hispanic

0.1691

1.184

NA

NA

NA

NA

Note: all unmarked variables significant at p<.OOO 1;

* significant at 0.0005

Hypothesis 1 Supported
The results of the logistic regressions predicting being female among all MI
discharges clearly indicate that the likelihood that a person admitted with a primary
diagnosis of MI is female increases over time. For AZ the likelihood of being female if
you have an MI admission increases by 1.50/0 per year; in MD it increases by 0.80/0 per
year, and in FL it increases by 1.1 % per year from 2000 through 2010. This is after we
have controlled for any changes in the composition of the MI populations that may be
due to race, ethnicity or age. It also controls for the likelihood of being diagnosed or
treated by angiography. While the

'"~raw"

frequencies in tables 1 and 2 shows that the

overall number of admissions with a primary diagnosis of MI has been decreasing over
time~

the results of the logistic models indicate that females make up an ever increasing

proportjon of MI admissions.

Thus~

the data supports our hypothesis that the proportion

of female Ml patients is increasing, and that this increase is not simply due to ageing.
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Presence of Diabetes and Obesity and Other Risk Factors
Each hospital admission record was exanlined for the presence of diagnosis codes
for diabetes (ICD-9 250.xx) and obesity (ICD-9 codes 278.xx, 259.9 and V85.xx). The
results of the descriptive analysis of the data are presented in Figures 1-3 below.

Figure 1a: Percent Women and Men with MI and Comorbid Obesity in AZ
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Figure Ib: Percent Women and Men with MI and Comorbid Obesity in FL

18
16
14
12
10
8
6
4

2

o
2000

2001

2002

2003

2004

2005

• % Obese Women

2006

2007

2008

2009

2010

%Obese Men

Figure 1c: Percent Women and Men with MI and Comorbid Obesity in MD
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Figure 2a: Percent Women and Men with MI and Cornorbid Diabetes in AZ
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Figure 2b: Percent Women and Men with MI and Cornorbid Diabetes in FL
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Figure 2c: Percent Women and Men with MI and Comorbid Diabetes in MD
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Figure 3: Percent Male and Female MI Patients with a COl11orbid Diagnosis of Obesity,
Diabetes or Both in AZ, FL, and MD frol11 2001 through 2010

50
45
40
35
30
25
20
15
10
5
0
2001
P<.OOOl

2002

2003

2004

2005

• % Women

2006

2007

2008

2009

2010

%Men

We compared the likelihood of AMI patients with a comorbid diagnosis of
diabetes and obesity being female using a logistic regression to predict the presence of
COlll0rbid diagnoses of obesity and diabetes by gender. The individual modeling results
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for the three states are presented in Table 7 below.

Table 7: Logistic regression models predicting the presence of an obesity or diabetes
comorbid diagnosis by gender~ controlling for year of hospital admission, age, race,
..
d receIpt
. 0 f anglop
. Iasty surgery or d"lagnostlc proce d ure.
ethnlcltyan
AZ
MD
FL
MD
FL
AZ
Odds Ratio

Odds Ratio

Odds Ratio

Intercept

-180.3

Female

0.1663

1.181

0.1316

1.141

0.2706

1.311

Year

0.0899

1.094

0.0724

1.075

0.0616

l.064

Age

-0.0125

0.988

-0.00807

0.992

-0.00742

0.993

Angiogram

-0.1878

0.829

-0.1834

0.832

-0.2185

0.804

Black race

0.4334

1.542

0.4368

1.548

0.4122

1.510

Hispanic

0.7394

2.095

NA

NA

NA

NA

Native Am.

1.1912

3.291

NA

NA

NA

NA

-145.2

-123.5

All variables significant at p<.OOO 1
Hypothesis 2 Supported
The results of the logistic regressions predicting the comorbid conditions of
obesity or diabetes in patients admitted with a primary diagnosis of MI increases over
time. For AZ the likehhood of having obesity or diabetes if you have an MI admission
increases by 9.40/0 per year. In MD it increases by 6.40/0 and in FL the increase is 7.5%
per year from 2000 through 2010. This is after we controlled for any changes in the
composltion of the diabetes or obesity in the M I population that may be due to race,
ethnicity~

or age. It also controls for the likelihood of being diagnosed or treated by an

angiogram. Fenlales in AZ are 18.1 % more likely than males to have the comorbid
disease of obesity or diabetes~ women in FL are 14.1 % more likely than men to be obese
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or have diabetes, while in MD the percentage is 31.10/0. The AMI patients with a
diagnosis of obesity or diabetes are 17.1 010 less likely to receive an angiogram in AZ,

16.80/0 less likely in MD, and 19.6% less likely in FL. As expected, black patients across
the three states are approximately 50% more likely than Caucasian patients to have a
diagnos1s code of diabetes or obesity. The prevalence of obesity and diabetes codes for
H1spanic and Native Americans in AZ 1S even higher than the prevalence noted for black
patient.

Presence of a comorbid condition in year 2010 that could obscure the AMI diagnosis.
We examined the data from all three states for the presence of a comorbid
diagnosis of chest pain, muscle strain, heart

bum~

gastric reflux disease or vague

complaints that could obscure a diagnosis of MI. Our hypothesis was that a higher
proportion of women with an MI than men have a comorbid diagnosis of a complaint that
could obscure MI signs and symptoms. Descriptive data are presented in Table 8 and

Table 9 and the 2010 AMI percentages. We also used a logistic modeling approach to test
this hypothesis noted in Table 10.
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Table 8: The percent of men and women in 2010 with a comorbid diagnosis based on
ICD-9-CM diagnosis codes describing females" signs and symptoms of M I in the states
of AZ, FL, and MD.
COMORBID ICD-9-CM DIAGNOSIS
CODE ADMISSION FOR Ml
PATIENTS IN 2010
786.0

DESCRIBED SIGNS
AND SYMPTOMS

Dy~pnea

and

FL

FL

MD

MD

AZ

AZ

MEN

WOMEN

MEN

WOMEN

MEN

WOMEN

54%

46(~o

55%

45%

(l3%)

37~~J

respiratory

abnonllu1itics
786.5

Chest Pain

57%

43%

54{j'o

46°/Q

66%

34{~o

780.7

Malaise and Fatigue

46(1~

54%

4()%,

54%)

49%

51%

7X7.02

Nausea alone

50°/;)

50%

SO'/o

sm'O

5m~

50%

719.41

Pain in Joint. Shoulder
Region

54%\

4(l%

62%)

38%

5W~'0

42 oJ()

729.5

Pain in Limb

44[%

56%

4W/'0

52~/o

53°A)

47%

7RO.96

Generalized Pain

17[%

83%

67%)

33%

33'yo

67°/r)

338.1

Acute Pain

(lO%

40 1ft)

100%)

0%

0%

O{~o

724.5

Backache. Unspecified

62%

38%.

48%

52'%

S9~/O

41%

780.4

Dizzi ness and
(jiddiness

47%

s3°'0

~7°/()

43%

50(~'o

50%

787.1

Hcartbum

57~;)

43%

16%,

R4%

0%

100%

530.RI

Esophageal
RefluxiGERD

54%

4 (,(J,o

52(~;)

48%

58%

42%

300.00

Anxiety State.

43%

57%

45'1()

55%

52%

4R°;/j

Unspecified

Table 9: The percent of men and women in 2010 with the Principal ICD-9-CM Diagnosis Code 410- for
MI in FL. SC. and MD.
AZ
AZ
MD
PRINCIPAL lCD~9-CM
MD
DESCRIBED SIGNS AND
FL
FL
DIAGNOSIS CODE for 2009
410-

SYMPTOMS
Acule Myocardial Inhtrction
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MEN
61%

WOMEN
39%

MEN

WOMEN

MEN

WOMEN

58%

42{~o

64°/;,

36%

Table 10: Logistic regression models predicting the presence of a comorbid diagnosis in
2010 admissions that could obscure the diagnosis of an AMI, for males and females,
controlling for age, race and use of angiography.

AZ

AZOR

FLOR

FL

MD

MDOR

Intercept

-l.5593

Female

0.3341

1.397

0.4243

1.528

0.3979

1.489

Age

0.00313

1.003

0.00237*

1.002

0.00480

1.005*

Angiogram

-0.521

0.949

-0.1808

0.835

-0.1670

0.846*

Black race

-0.1253

0.882

~O.3236

0.724

-0.2600

0.771

Hispanic

NA

NA

NA

NA

NA

NA

Native

NA

NA

NA

NA

NA

NA

-1.4667

-1.3049

Am.

* p<.0050; a]] other variable significant at p<.OOO 1
Hypothesis 3 Supported
The results in Table 10 above show a consistent effect of gender across the model
for the three states. Women with an AMI in AZ in 2010 are 39.7% more likely than men
to have one or more recorded diagnoses that could make it difficult to diagnose the AMI.
The rate for women in FL is 52.8% higher than for males, and in MD the rate for women

is 48.9% higher than the rate for males. This is after controlling for the variation in the
presence of these comorbidities due to age, use of an angiogram, and black race. The
variables that controlled for Hispanic culture and Native American race were not
significant.
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DISCUSSION
The research project was to determine if our speculations concerning the age-

specific female AM I rates increased more than males over the years. However, the data
indicated the trend of AMls were decreasing in both males and females, but based on the
proportional percentage of women, AMI increased year over year as compared to the
males. We also concluded that the African American females were more likely to have an
AMI at a much higher percentage than the Caucasian females. The research did support
our hypothesis, and it was significant that the percent of women with comorbid
conditions of both diabetes and obesity was increasing at a faster rate than men
presenting with these same risk factors. Women are more likely to have one or more of
these

comorbidities~

moreover A friean American women are even at a greater risk than

Caucasian women. Other findings pertaining to our research questions were in relation to
the signs and symptoms of AMI in women which are often overlooked when presenting
to the ER. The signs and symptoms of women may mimic other conditions or diseases.
We reviewed and analyzed the ICD-9-CM codes as determined in the literature review
that best described the slgns and symptoms often indicative of those in the female
population. The findings were significant according to table 10 and women were more
likely than men to possess one or more of these diagnoses so as to make it difficult to
diagnose an AMI. The research did conclude that AMI women often present to the ER
with G ERO, fatigue, anxiety, and general pain which may go undiagnosed due to the
obscure complaint. However, men present with the traditional AMI signs and

symptoms~

such as chest pain, dyspnea, shoulder and joint pain which are more easily identified and
treated. One of the most remarkable findings was the percentage of wonlen diagnosed
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with an AM I and yet they were still less likely to receive an angiogram as compared to
AM I positive men.

These findings are meaningful as discussed in some of the

literature~

however literature does not indicate the critical number of women which go

untreated.

We wanted to test our hypotheses and we chose to use the UB04 Hospital

Discharge Record. According to the literature and our hypotheses~ it was important to
review data over time. We wanted 10 years of data to include sex, race, ethnicity,
diagnosis

codes~

procedure codes and age. The data were available for three states that

met our criteria, which were Arizona, Florida, and Maryland.
The first analysis was to determine if there was an increase in the number of
patients presenting to the ER over the last ten years, and if women increased more than
the rate observed in men. The hospital discharge data from the three states listed above
indicated the trend of AMI had actually decreased from 2000 to 20] O. We speculated
that because heart disease is the leading cause of death for males and females, there
would have also been an increase in hospltal discharges of patients diagnosed with AMI.
However, over the last decade there was a 20 percent decrease in the number of patients
diagnosed with AMI in the three states indicated between 200 I and 2010. The average
age of these patients was from 66.7 to 69.8, and the average age decreased by nine
months from 200 I to 2010. Maryland had the lowest mean age of AMI diagnosis of 66.7
as noted in Table 4. This held true for both males and females, however, the AMI rate in
proportion to females increased year over year, a trend that was compounded by
secondary risk factors, which resulted in an even great number of diagnoses year over
year.
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The overall decrease in the AMI rate over the last decade may be associated with
the public-health initiatives which started in 2002 to educate the general public on cardiac
health and encouraged healthy hfestyles. During this period individuals became more
aware of heart dlsease and the need for proper nutrition and regular exercise to help
improve overall fitness.
The general

public~

as well as heahhcare professionals were more aware of the

traditional signs and symptoms of a heart attack and the critical compromise it places on
an individuaL In understanding the importance of seeking medical treatment for
improved

outcomes~

it became apparent to some individuals to go to an ER, which at

times assisted in preventing or decreasing the MI due to pharmacological therapy.
The improvement in the primary prevention over the last decade with
phannacological therapy has lowered the incidence of CVDs and AMls in patients, which
n1ay have been at a greater risk for an AMI or subsequent AMIs.
The American College of Cardiology (ACe) and the AHA have during the last 10
years presented guidelines for the emergency care of patients entering the hospital with a
possible AMI. The guide1ines stated that the patient within 90 minutes of arrival into the
ED should be diagnosed and treated, which is often called

Hdoor-to-balloon'~.

Research has detelmined the faster the patient is diagnosed and treated, the more

likely he or she will have improved outcomes. The decline in the number hospital
discharge diagnoses of AMI is likely due to factors in process improvement initiatives
with a more defined standard of care. The patients presenting to the ER with ACS are
much more likely to receive the same treatment in Arizona,
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Florida~

and Maryland.

However, hospitals may vary and establish their unique standards but generally
follow the recommendations of the Ace and AHA of the appropriate treatment or

procedure based on the patient's classification. The use of phannacological therapy such
as thrombolytic therapy and PCI are now more often received as indicated in the cardiac
patient, particularly in the AM I male population. However, female patients are often
misdiagnosed and go untreated, whereas males are more likely to be treated as
recommended in the guidelines for ·"Chest Pain". The standard treatment and procedures
recommended by the ACe and AHA assist in decreasing the mortality rate (Braunwald et

aI., 2000).
Although the overall number of admissions with the primary diagnosis of AMI
has been decreasing over time, the likelihood of being female plus the primary diagnosis

of MI are increasing over time.
In Table 6, the logistic regression model predicted the likelihood of being female
for all admissions with a primary diagnosis of MI in the three states from 2000 to 2010.
Moreover, we controlled for changes in the composition of the MI population~ and the
results indicated women with the primary dlagnosis of AM I upon admission increased in
all three states as follows: Arizona, 1.5 percent per year; Maryland, 0.8 percent per year:

and Florida, 1.1 percent per year. This logistic model supports our hypothesis by
detennining the proportion of AM I female patients is growing year over year and not due
simply to aging.
The presence of diabetes and obesity has become a public heaHh issue in the
young, adolescent, middle age. and elderly population. A descriptive analysis of the data
from the three states describe the female population diagnosed with AMI based on
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hospital admission records as having a higher percentage of diabetes and obesity upon
presentation to the hospital than men. The AZ descriptive analysis for men and women
with AMI from 2000 to 2010 along with comorbidity of obesity had a higher percentage
of females than males for eight out of 11 years. However, in Florida and Maryland the
percentage of females with obesity was greater than males every year. In a11 three states
the percentage of MI patients with the comorbid condition of obesity had at least doubled
or tripled from 2000 to 2010.
The percent of females with a diagnosis of AMI and the comorbidity of diabetes
were always greater than the male population within these states. Maryland had the
highest with 42 percent in 2009 and 2010.
When combining the three states for the AM I patients with obesity, diabetes or
both comorbidities from 2001 to 2010, the females again exceeded the males every year.
Figure 1-3 indicates females diagnosed with AMI will more likely have additional risk
factors or comorbidities than their male counterparts.
The analysis also describes both the AMI female and male population with
diabetes increasing in

2008~

in some cases by at least 5 percent more than the previous

year. Although there has not been an increase in the AMI diagnosis rate over the last 10
years, the patients who are diagnosed may be sicker than before, plus requiring more
medical care.
The decrease in the number of AMI diagnoses by the hospital discharge data from
200 I to 2010 does not imitate trends observed within the minority population. The
percentage of the African American population diagnosed with AMI increased.
Maryland had the highest percentage increase, from 17.46 percent in 2001 to 24.16
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percent in 2010, whereas Florida increased from 6.61 percent to 9.45 percent, and the
percent of Arizona's minority population diagnosed with AMI, including blacks, Native
Americans and Hispanics, increased from 1.73 percent to 2.66 percent. We included these
races due to a higher Native American and Hispanic population in Arizona compared to
the other two states.
Black patients are more likely to receive the diagnosis of obesity or diabetes or
both, which increases their risk factors of having an AMI. In Arizona, Hispanics and
Native Americans are more likely than the black population to be diagnosed with obesity
or diabetes or both, which increases the overall risk factors associated with AM I.
As the overall population trends decrease, the minority population increases over
time. The future trends of AMI may increase rather than decrease within the entire
population as the minority population increases. According to the 2010 U.S. Census
Bureau, the black population had a 12.3 percent increase in the number of AMI
diagnoses., compared to a 5.7 percent increase among Caucasians.

It has been determined in this study that the female population within the three
states of Florida, Maryland and

Arizona~

as based on the Hospital Discharge Summary,

indicates females diagnosed with AMI are more likely to have a comorbid

condition~

which often can obscure signs and symptoms of AMI when presenting to the ER.
The signs and symptoms of women often differ from those of men. Women may
experience back, jaw or neck

pain~

shortness of breath or dyspnea nausea, vomiting,

fatigue, general weakness, anxiety, GERD, heartburn and overall discomfort. Men, on
the other hand, have traditional symptonlS such as chest pain, discomfort in the ann,
shoulder and neck, as wel1 as shortness of breath. Women are more likely to be
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misdiagnosed and sent home only to become more acute as the condition exacerbates,
thus decreasing the chance of survival.
We examined the data from these states for the presence of a comorbid diagnosis
of chest pain, muscle strain, heart bum, gastric reflux disease or vague complaints which
may mask the diagnosis of MI.

It was detennined from Table 8 that the described signs and symptoms of fatigue,
pain in limb, heart bum, anxiety and generalized pain and nausea, were noted to present
in women upon admission to the ER compared to the men presenting to the ER. MD had
the greater percentage of 84 percent as compared to men at 16 percent. The comorbid
diagnoses of malaise and fatigue were indicated in 51 to 54 percent of women across the
states, along with anxiety from 48 to 57 percent, as shown in Table 8.
Men presented with the classical signs and symptoms of chest pain, dyspnea, and
shoulder pain. Chest pain and dyspnea presented in 54 to 66 percent of men, followed by
shoulder and back pain (48 to 66 percent), within the AMI male population.
It was interesting to note the population with the highest percentage of AMI

admissions for women in 20] 0 was MD at 42

percent~

which also had the highest

consistent percentage of women presenting with heartburn, at 84

percent~

along with

fatigue (54 percent) and anxiety (55 percent).
Arizona had the greatest percentage of men with Ml, at 64

percent~

in addition to

the most men with the comorbid diagnosis of chest pain (66 percent), plus dyspnea (63
percent)~

as well as a high percentage of shoulder (58 percent) and back pain 59 percent).

This was described in table 2 and table 8. These findings accept the hypothesis that a
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higher proportion of women with an AMI have a comorbid diagnosis of complaints,
which could obscure the signs and symptoms of an AMI.
According to the logistic regression model (Table 10), which predicted the
presence of a comorbid diagnosis in the 2010 admissions obtained from the discharge
summary data~ the comorbid diagnosis might possibly obscure the diagnosis of AMI in
both men and women across the three states. However, the analysis indicated women are
more I1kely to have one or more diagnoses, which would make diagnosis and AMI
difficult. The women in Arizona are 39.7 percent more likely than men to have one or
more obscure diagnoses, and in Florida it is 52.8 percent higher, along with the MD rate
of 48.9 percent. Women are more likely than men to have one or more diagnoses which
would hinder the diagnosis of AMI. These findings are significant at p<.OOO 1.
The proportion of fenlale M I patients has increased over time in all three states,
plus the female is more likely to have one or more obscure diagnoses, which makes
diagnosis of an AMI more complex. Not only is the diagnosis difficult to assess, but it is
increasing yearly in women with

obesity~

diabetes or both. The populations' risk among

both men and women is increasing in order to achieve a well-timed diagnosis of AMI
upon presentation to the ER and the ability to provide life-saving treatment according to
the AHA and ACe guidelines. The likelihood that women will receive the necessary
treatment is lower than men, even if they are diagnosed with AMI.
We observed from the data that women who are admitted with the primary
diagnosis of AMI are much less likely than the AMI males to receive an angiogram. It
was also detennined that women diagnosed with AM l~ along with obesity or diabetes,
were less likely to obtain an angiogram. We did lin1it our study to analyzing the data
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based on one procedure which is more often indicative of a STEMI. It would be
interesting to also review AMI patients undergoing pharmacological therapy first and to
note the disparities. In Arizona, women are 17. I percent less likely to receive an
angiogram, compared to 16.8 percent in Maryland and 19.6 percent in Florida. It is also
noted across the three states that black patients are 50 percent more likely to be diagnosed
with diabetes and obesity compared to Caucasian patients, a difference that is even more
pronounced in Arizona, where Hispanic and Native Amerlcan patients outnumber black
patients, as indicated in Table 7. Much of the findings in the literature stated much of the
same, however there was not as much evidence of disparities as noted in this study.
In summary, the

~~raw"

frequencies data as presented in Tables 1 and 2 show the

overall primary AM I admissions diagnoses are decreasing over tin1e by approximately 20
percent. However, the number of females in proportion of AMI admissions dlagnosis is
increasing over time, a trend that is linked to not just the aging female population, but
also lifestyle changes over the past decades. Women are under more stress than ever
before due to the country's economic climate as well as the burden of juggling family,
work and social responsibilities. These components can affect their general well-being,
which has its associated health implications.
The descriptive analysis of the three states indicated the prevalence of patients
with diabetes and obesity has increased from 2000 to 2010 for both males and fenlales.
The number of females diagnosed with AMI is exceeding the number of males based on
hospital admission records in all three states with the presence of diabetes, obesity or
presenting with both comorbidities. The percent of male and female MI patients with the
comorbid diagnosis of obesity, diabetes, or both was significant P<.OOO 1 in all states
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from 200 1 to 2010. The logistic regression models indicated patients diagnosed with

AMI will more than likely over time present with one or more

comorbities~

plus females

are at a greater risk than men.
As the potential risk for AMI in females increases, the ability to correctly
diagnose and treat females decreases. The signs and symptoms within the female
population with AM I differ compared to men and are often not recognized. When these
symptoms go unnoticed the female is improperly diagnosed and does not receive
appropriate treatment.

However~

even if the female is properly diagnosed, she is less

likely to receive PC] as compared to men. Minorities are at a greater risk than female
patients diagnosed with AMI. African American AMI patients have a greater chance of
one or more comorbidities, which places them at a greater risk for AMI. Furthermore,
Hispanic and Native Americans exceed the African Anlerican population for
comorbidities and their risk will be larger.

Limitations
Some of the limitations of this study were utilizing the secondary data of only
three states as compared to the entire country. We were able to provide a snapshot based
on the three states 10 year hospital discharge records to determine the disparities in
females and AMI

diagnosis~ treatment~

and intervention. We must now enhance our

understanding of the critical needs and extract data based on the social and economic
demographics due to the high risk factors. We did not detennine the mortality rate of
females as compared to males as to the overall lack of treatment or intervention. We did
limit our research to only the overall

trends~

conlorbidities risk
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factors~

treatment and

intervention for females. There is yet another question as to trend of mortality in the
female and nlinority population. The study also did not take into account the geographic
location with the highest increase incidence of AMI by region and population within each
state based on gender, race, and ethnicity, economic and social factors. The study would
have benefited in acknowledging the time between females presenting to the ER with
signs and synlptoms of an AMI to the time the female received intervention or treatment
for the AMI to detennine the average length of time as compared to the males preening
based on the ACC guidelines. However, due to the limits within the secondary data set
we were unable to detennine if there is a disparity for females to receive the intervention
or treatment within the 90 minute timeline for increase quality outcomes.

Project Significance
The percentage of females diagnosed with AMI is increasing year over year, as is
the percentage of comorbidities~ thus far females remain at a higher risk for an AMI and
will often go undiagnosed and treated. Due to these findings it may be assumed females
have a higher nlortality rate than men diagnosed with AMI. Additional data are needed
to improve our understanding and provide implications based on lack of AMI
intervention within the female population in relation to the mortality rates. The ongoing
increase in the incident of obesity and diabetes as communicated by the CDC along with
other government and state agencies must be a public focus in order to adequately
provide ll1edical management to subjects with an increased risk of AMI. The ability to
recognize the signs and symptoms is imperative for hea1thcare professionals, females,
and minorities to achieve prevention, treatment, intervention and quality outcomes.
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We must acknowledge and understand the differences in cardiac health risk
factors among males and females in order to provide the necessary measures for
improvement when females present with an AM I to the ER. Both the ACe and AHA
have established guidelines and noted the importance of a timely diagnosis of those
presenting with an AMI, especially a STEM!. We must first rekindle and impart a
consistent message on initiatives such as the NHLBI's "'The Heart Truth" in order to
educate the public on critical awareness within the female population and heart disease.
There must be a proactive approach on the local, state and federal level by means of
public policies with reference to health equities for women and minorities. Minority
females exceed the risk of the general female population and often have the least
accessibility to healthcare \vithin the United States.
There is a need for preventive screening~ education, programs, and advocates
working through public policy to make changes as well as provide innovate technology
for the improvement of public health. The population with the most needs is often the
one with the least amount of access to medical care.
In proactively communicating, advocating and expressing concerns over these
healthcare disparities~ we are also addressing other public health issues, such as obesity
and diabetes. Both conditions are a public health risk and contribute to negative cardiac
hea1th for females. There is a need to promote a healthy lifestyle and not limit the focus
to a single condition or risk factor. Advocating for the well-being of the whole person is
imperative in order to inlprove quality of life and decrease demands of an already
overstressed healthcare system.
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Future Significance
Healthcare professionals must be accountable and stay abreast of the current and
future state of healthcare. Educating oneself about heart disease is important in
understanding the risks posed to females. The use of the mainstream media as well as
social networking will enable the heart health message to cross the border both socially,
demographically and socioeconomically. Partnering with physicians, healthcare
professionals, academic and community medical centers, public health agencies, and
vendors will only enhance our ability to reach more females by providing the most up-todate concepts, trends, research, and innovative technology to manage the overall quality
of life within the female population.
There is much to be determined in order to implement a strategy for increased
outcomes and reduce the year over year increase of AM I in particular population groups
as we have noted in the project. In continuing to better understand I would regionally
segment the United States and review extensively the social demographics to detennine
the areas that have the highest prevalence of comorbidities within the female population.
Also needed is a closer examination of the regions with the greatest increase in
percentage of AMI diagnosis over time in order to determine what if any changes
occurred within the population during the period in question, and if this change occurred
in other areas as well. I would like to examine the mortality rate of females and any
infonnation on the risk stratification within the female and minority female population
and readmission rates within the first year of discharge as compared to males. It would
also be important to determine the number of females diagnosed and undergoing
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appropriate treatment within the 90-minute AHA and ACe guidelines and their outcomes
as compared to males.

CONCLUSION
We observed a decreasing number of AMIs over time, but an increasing
proportion of AMI admissions being female, and an especially high rate observed for
minority women. Women with an AMI also have a higher rate of comorbid obesity
and/or diabetes than observed in men. In addition, women are more llkely to have
comorbid signs or diagnoses with symptoms that could mimic AM I symptoms, and thus
confuse the rapid diagnosis of an AMI. National guidelines stress the importance of a
timely diagnosis of patients presenting with an AM I. To assure equity in access to quality
care for AMI patients, both n1edical professionals and the public may need education
focused on the increasing rate of AM I within the female

population~

and that minority

females greatly exceed the AMI risk of the genera] female population.

Furthermore~

a

change in guidelines to increase the use of laboratory tests for AMI for women with
comorbid conditions that could obscure MI symptoms should be considered, especially
for minority women.
In conclusion, the study was based and analysis was perfonned on the

states~

AZ,

FL, and MD due to limited availability based on ten years of State Hospital Discharge
Records. The findings included in this study are not necessary indicative of the entire
United States but of these three states.
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